BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Cellectar Biosciences (Formerly Known As Novelos Therapeutics, Inc.)  

3301 Agriculture Drive

Madison  Wisconsin  53716  U.S.A.
Phone: 608-441-8120 Fax: 608-441-8120


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical

Segment
Drug Discovery





 Company News
Cellectar Biosciences  (NVLT) Announces Participation In Two Upcoming Investor Conferences In September 9/5/2014 8:01:16 AM
Cellectar Biosciences  (NVLT) Announces Acceptance Of Investigational New Drug Application To Evaluate I-131-CLR1404 In Clinical Trials In Relapsed Or Refractory Multiple Myeloma 9/4/2014 8:59:37 AM
Cellectar Biosciences  (NVLT) Reports Second Quarter 2014 Financial Results And Recent Highlights 8/21/2014 7:47:19 AM
Cellectar Biosciences  (NVLT) Announces Closing Of Public Offering And Partial Exercise Of Underwriter's Over-Allotment Option 8/21/2014 7:44:46 AM
Cellectar Biosciences  (NVLT) To Host Conference Call On August 20th To Discuss Second Quarter 2014 Results And Provide Quarterly Update On Development Progress 8/19/2014 6:55:27 AM
Cellectar Biosciences  (NVLT) Announces Pricing Of $12,500,000 Public Offering And Listing On The Nasdaq Capital Market 8/15/2014 7:51:47 AM
Cellectar Biosciences  (NVLT) Files Investigational New Drug Application To Evaluate I-131-CLR1404 In Clinical Trials In Relapsed Or Refractory Multiple Myeloma 8/11/2014 7:38:21 AM
Cellectar Biosciences  (NVLT) Appoints Chad J. Kolean Chief Financial Officer 7/9/2014 8:45:57 AM
Cellectar Biosciences  (NVLT) Announces 1-For-20 Reverse Stock Split And Reduction In Authorized Shares Of Common Stock 6/13/2014 8:26:30 AM
Cellectar Biosciences  (NVLT) Announces Presentations At 2014 American Society of Clinical Oncology Annual Meeting 5/30/2014 8:26:34 AM
12345678910...